A Study of Sodium Oligomannate (GV-971) in Participants With Mild to Moderate Alzheimer's Disease

Clinical trial NCT04520412 · SUSPENDED

Trial details

NCT number: NCT04520412
Sponsor: Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
Status: SUSPENDED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2020-10-27
Primary completion: 2025-12-01
Enrollment: 2046

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.